At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development of new treatments for severe chronic pain conditions. Zyneyro’s CEO Peter Horn Møller talks with BioStock about the collaboration and overall vision.
Read the interview here: Zyneyro’s CEO on the collaboration with CombiGene